mRNA |
ABT-263 |
FIMM |
pan-cancer |
AAC |
0.061 |
0.7 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
CGP-082996 |
GDSC1000 |
pan-cancer |
AAC |
-0.022 |
0.7 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
0.064 |
0.7 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |